Moisand Fitzgerald Tamayo’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-321
| Closed | -$11.3K | – | 789 |
|
2022
Q4 | $11.3K | Hold |
321
| – | – | ﹤0.01% | 304 |
|
2022
Q3 | $9K | Sell |
321
-1
| -0.3% | -$28 | ﹤0.01% | 293 |
|
2022
Q2 | $17K | Hold |
322
| – | – | ﹤0.01% | 237 |
|
2022
Q1 | $18K | Hold |
322
| – | – | 0.01% | 141 |
|
2021
Q4 | $18K | Hold |
322
| – | – | 0.01% | 211 |
|
2021
Q3 | $15K | Hold |
322
| – | – | 0.01% | 217 |
|
2021
Q2 | $16K | Hold |
322
| – | – | 0.01% | 222 |
|
2021
Q1 | $14K | Hold |
322
| – | – | 0.01% | 190 |
|
2020
Q4 | $15K | Hold |
322
| – | – | 0.01% | 187 |
|
2020
Q3 | $15K | Hold |
322
| – | – | 0.01% | 173 |
|
2020
Q2 | $16K | Sell |
322
-20
| -6% | -$994 | 0.01% | 163 |
|
2020
Q1 | $16K | Hold |
342
| – | – | 0.01% | 158 |
|
2019
Q4 | $20K | Hold |
342
| – | – | 0.01% | 162 |
|
2019
Q3 | $18K | Hold |
342
| – | – | 0.01% | 162 |
|
2019
Q2 | $17K | Hold |
342
| – | – | 0.01% | 166 |
|
2019
Q1 | $18K | Hold |
342
| – | – | 0.01% | 164 |
|
2018
Q4 | $16K | Hold |
342
| – | – | 0.01% | 166 |
|
2018
Q3 | $17K | Hold |
342
| – | – | 0.01% | 180 |
|
2018
Q2 | $17K | Hold |
342
| – | – | 0.01% | 165 |
|
2018
Q1 | $17K | Hold |
342
| – | – | 0.01% | 175 |
|
2017
Q4 | $15K | Hold |
342
| – | – | 0.01% | 174 |
|
2017
Q3 | $17K | Buy |
+342
| New | +$17K | 0.01% | 173 |
|
2016
Q2 | – | Sell |
-614
| Closed | -$31K | – | 107 |
|
2016
Q1 | $31K | Hold |
614
| – | – | 0.03% | 111 |
|
2015
Q4 | $31K | Buy |
+614
| New | +$31K | 0.03% | 106 |
|